A
Amphastar Pharmaceuticals, Inc. (AMPH)
NMS – Real Time Price. Currency in USD
19.01
-0.52 (-2.66%)
At close: Mar 27, 2026, 4:00 PM EDT
19.03
+0.02 (0.11%)
After-hours: Mar 27, 2026, 7:59 PM EDT

NMS – Real Time Price. Currency in USD
19.01
-0.52 (-2.66%)
At close: Mar 27, 2026, 4:00 PM EDT
19.03
+0.02 (0.11%)
After-hours: Mar 27, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.02 | 2.52 | 10 | |
| Quick ratio | 2.90 | 1.78 | 10 | |
| Debt to Equity | 0.83 | -0.80 | 6.0 | |
| Debt to Assets | 0.39 | 0.73 | 6.0 | |
| Interest coverage | 5.37 | -13.90 | 10 | |
| Weighted average score | 8.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 499M | 644M | 732M | 720M | 720M |
| Gross Profit | 239M | 344M | 361M | 341M | 341M |
| Operating Income | 107M | 200M | 205M | 140M | 140M |
| Net Income | 91M | 138M | 160M | 98M | 98M |
| EBITDA | 136M | 241M | 263M | 204M | 204M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 2.09 | -2.47 | 2.0 |
| Next quarter | 5.24 | -6.4 | 3.0 |
| Current year | 5.09 | 1.06 | 4.0 |
| Next year | 4.76 | 6.26 | 4.5 |
| Weighted average score | 3.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -4.54 | 40.8 | -21.5 | -47.93 | 3.3 |
| Y/Y | -1.82 | -35.64 | -20.64 | 48.02 | 3.3 |
| 3y average | 13.7 | 9.33 | 23 | 37.81 | 8.5 |
| 5y average | 16.04 | 880.5 | 45.37 | 61.3 | 9.8 |
| Weighted average score | 6.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $656.0M significantly exceeds cash reserves ($170.4M), raising financial stability concerns
Total current assets $636.0M exceed Total current liabilities $158.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (5x) indicates the company easily manages its debt payments
The company generates positive free cash flow $24.6M, supporting its financial health